Inventor · disambiguated record
Suprit Dilip Saoji
Also filed as: SAOJI SUPRIT DILIP
4 granted patents·7 pending applications·29 citations·filing 2022–2025
76Inventor score
Technology areasA61K
Top patents by PatentIndex Score
11 records- 0196US11679105B1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Jun 20, 2023·11 cites·13 claims
- 0296US11590122B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Granted Feb 28, 2023·14 cites·12 claims
- 0394US12357627B2Pharmaceutical compositions of cabozantinibAZURITY PHARMACEUTICALS INC·Filed 2024·Granted Jul 15, 2025·2 cites·18 claims
- 0493US12138255B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 12, 2024·2 cites·6 claims
- 0582US2025302819A1Pharmaceutical compositions of cabozantinibAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0677US2024131018A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 0772US2022387418A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 0870US2025248987A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 0959US2024189229A1Liquid pharmaceutical compositions of baclofen for oral administrationANI PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1059US2022362235A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 1159US2022280500A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →